Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors
Abstract
Purpose: The value of the dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) in differentiating benign and malignant soft tissue tumors was investigated.
Materials and methods: Turbo FLASH DCE-MRI was performed on 22 subjects (2–74 years) with soft tissue tumors. Enhancement in the first min (Emax/1), second min (Emax/2) and maximum peak enhancement (Emax), and steepest slope were calculated. Discriminant analyses were performed to reveal parametric differences of benign and malignant lesions.
Results: Diagnosis of benign (N = 10) tumors were hemangioma (n = 3), neurogenic tumor (n = 3) lipoma (n = 2), giant cell tumor (n = 1) and desmoid (n = 1), whereas malignant lesions (N = 12) were classified as liposarcoma (n = 5), malignant fibrous histiocytoma (n = 5) and synovial sarcoma (n = 2). For malignant lesions Emax/1 was 65–198%, Emax/2 was 65–145%, Emax was 78–198%, and steepest slope was 1.45–4.06. For benign lesions these values were 4–98%, 5–105%, 7–125% and 0.67–2.57, respectively. To determine the relation between the variables analysed, Pearson correlation coefficients were calculated. Emax was found to be highly correlated with other variables (rxy>0.86, P < 0.0001). Consequently, this variable was excluded from the discriminant analysis. In order to determine discrimination of malignant and benign tumors using Emax/1, Emax/2, and steepest slope of the enhancement curve logistic regression was applied to the above mentioned data. When combined these parameters had a 95.5% of overall accuracy in classifying benign and malignant lesions (P = 0.004).
Conclusion: DCE-MRI parameters that thought to be the surrogate markers of tumoral microcirculation and tissue perfusion provides a specific preoperative diagnosis. Dynamic imaging parameters are therefore advocated for monitoring the effect of chemotherapy in soft tissue tumors.
Keywords: Dynamic contrast enhanced MRI, Semiquantitative enhancement parameters, Soft tissue tumors, Differential diagnosis
To access this article, please choose from the options below
PII: S0720-048X(04)00137-8
doi:10.1016/j.ejrad.2004.04.012
© 2004 Elsevier Ireland Ltd. All rights reserved.
